Replies to post #1896 on Perspective Therapeutics Inc (CATX)

[Dennisb68]

Yes, I find this VERY positive.

"Given ISR’s robust cash position and current burn rate, the company will not need any additional cash for at least the next five years. This completely takes out the dilution risk, which is usually associated with early stage companies like IsoRay."